BioNanomatrix, Inc. develops nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. The companyâ€™s technology provides analysis of genomic, epigenomic, and proteomic information with sensitivity at the single molecule level. Its products are used in genetic diagnostics, personalized medicine, and biomedical research applications. The company was founded in 2003 and is based in Philadelphia, Pennsylvania.
Current Team (6)Update
Past Team (4)Update
Funding Rounds (5) - $49.1MUpdate
Board Members and Advisors (4)Update
Private investment firm of Gordon Gund, principal owner of Cleveland Cavaliers National...
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on...
Battelle Ventures, L.P., and its affiliate fund, Innovation Valley Partners (IVP), have a...
Knoxville, Tenn.-based Innovation Valley Partners (IVP) is the affiliate fund of Battelle...
9640 Towne Centre Drive
San Diego, CA 92121